| RS2545249385 |
ABCB11
|
Health Risk |
Pathogenic |
ABCB11-related disorder, ABCB11-related disorder |
| RS2545249795 |
ABCB11
|
Health Risk |
Likely pathogenic |
Benign recurrent intrahepatic cholestasis type 2, Benign recurrent intrahepatic cholestasis type 2 |
| RS2545250765 |
DES
|
Health Risk |
Likely pathogenic |
Desmin-related myofibrillar myopathy, Desmin-related myofibrillar myopathy |
| RS2545250857 |
DES
|
Health Risk |
Likely pathogenic |
— |
| RS2545251600 |
DES
|
Health Risk |
Likely pathogenic |
Desmin-related myofibrillar myopathy, Desmin-related myofibrillar myopathy |
| RS2545252983 |
PINK1
|
Health Risk |
Pathogenic |
Autosomal recessive early-onset Parkinson disease 6, Autosomal recessive early-onset Parkinson disease 6 |
| RS2545253039 |
PINK1
|
Health Risk |
Likely pathogenic |
Autosomal recessive early-onset Parkinson disease 6, Autosomal recessive early-onset Parkinson disease 6 |
| RS2545253097 |
DES
|
Health Risk |
Likely pathogenic |
Desmin-related myofibrillar myopathy, Desmin-related myofibrillar myopathy |
| RS2545253453 |
DES
|
Health Risk |
Pathogenic |
Desmin-related myofibrillar myopathy, Desmin-related myofibrillar myopathy |
| RS2545254803 |
DES
|
Health Risk |
Pathogenic |
Desmin-related myofibrillar myopathy, Desmin-related myofibrillar myopathy |
| RS2545254942 |
MYO15A
|
Health Risk |
Likely pathogenic |
— |
| RS2545254961 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2545255158 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2545255266 |
DES
|
Health Risk |
Pathogenic |
Desmin-related myofibrillar myopathy, Desmin-related myofibrillar myopathy |
| RS2545255397 |
DES
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Desmin-related myofibrillar myopathy |
| RS2545255528 |
SLC25A12
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2545255549 |
DES
|
Health Risk |
Likely pathogenic |
Desmin-related myofibrillar myopathy, Desmin-related myofibrillar myopathy |
| RS2545256087 |
ABCB11
|
Health Risk |
Pathogenic |
Progressive familial intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 2 |
| RS2545258135 |
MYO15A
|
Health Risk |
Likely pathogenic |
— |
| RS2545259458 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2545259625 |
PINK1
|
Health Risk |
Likely pathogenic |
PINK1-related disorder, Autosomal recessive early-onset Parkinson disease 6 |
| RS2545261867 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2545261985 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2545262131 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2545262156 |
MYO15A
|
Health Risk |
Likely pathogenic |
Rare genetic deafness, Rare genetic deafness |
| RS2545264595 |
PINK1
|
Health Risk |
Pathogenic |
Autosomal recessive early-onset Parkinson disease 6, Autosomal recessive early-onset Parkinson disease 6 |
| RS2545264703 |
DES
|
Health Risk |
Conflicting classifications of pathogenicity |
Desmin-related myofibrillar myopathy, Desmin-related myofibrillar myopathy |
| RS2545264805 |
DES
|
Health Risk |
Likely pathogenic |
Desmin-related myofibrillar myopathy, Desmin-related myofibrillar myopathy |
| RS2545265594 |
MYO15A
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS2545265597 |
FOXP1
|
Health Risk |
Likely pathogenic |
Intellectual disability-severe speech delay-mild dysmorphism syndrome, Intellectual disability-severe speech delay-mild dysmorphism syndrome |
| RS2545266499 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2545266506 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2545266580 |
ABCB11
|
Health Risk |
Pathogenic |
— |
| RS2545266793 |
ABCB11
|
Health Risk |
Likely pathogenic |
Benign recurrent intrahepatic cholestasis type 2, Benign recurrent intrahepatic cholestasis type 2 |
| RS2545266943 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2545267203 |
ABCB11
|
Health Risk |
Likely pathogenic |
Benign recurrent intrahepatic cholestasis type 2, Benign recurrent intrahepatic cholestasis type 2 |
| RS2545267498 |
ABCB11
|
Health Risk |
Likely pathogenic |
Benign recurrent intrahepatic cholestasis type 2, Benign recurrent intrahepatic cholestasis type 2 |
| RS2545267790 |
PINK1
|
Health Risk |
Likely pathogenic |
Autosomal recessive early-onset Parkinson disease 6, Autosomal recessive early-onset Parkinson disease 6 |
| RS2545268569 |
MYO15A
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS2545268573 |
NBEAL2
|
Health Risk |
Likely pathogenic |
Gray platelet syndrome, Gray platelet syndrome |
| RS2545268950 |
MYO15A
|
Health Risk |
Likely pathogenic |
— |
| RS2545270997 |
ABCB11
|
Health Risk |
Pathogenic |
— |
| RS2545271813 |
NBEAL2
|
Health Risk |
Likely pathogenic |
NBEAL2-related disorder, NBEAL2-related disorder |
| RS2545271850 |
ABCB11
|
Health Risk |
Likely pathogenic |
Benign recurrent intrahepatic cholestasis type 2, Benign recurrent intrahepatic cholestasis type 2 |
| RS2545271927 |
ABCB11
|
Health Risk |
Likely pathogenic |
Benign recurrent intrahepatic cholestasis type 2, Benign recurrent intrahepatic cholestasis type 2 |
| RS2545271954 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2545272260 |
ABCB11
|
Health Risk |
Pathogenic |
Progressive familial intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 2 |
| RS2545272431 |
ABCB11
|
Health Risk |
Pathogenic |
— |
| RS2545272467 |
MYO15A
|
Health Risk |
Likely pathogenic |
Rare genetic deafness, Rare genetic deafness |
| RS2545275989 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2545276155 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2545276246 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2545276422 |
MYO15A
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS2545276437 |
MYO15A
|
Health Risk |
Likely pathogenic |
— |
| RS2545277848 |
KDR
|
Health Risk |
Likely pathogenic |
Tetralogy of Fallot, Tetralogy of Fallot |
| RS2545277918 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2545278113 |
TRIM37
|
Health Risk |
Likely pathogenic |
Mulibrey nanism syndrome, Mulibrey nanism syndrome |
| RS2545280165 |
MYO15A
|
Health Risk |
Likely pathogenic |
— |
| RS2545280168 |
MYO15A
|
Health Risk |
Likely pathogenic |
— |
| RS2545280195 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2545280490 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2545280961 |
MYO15A
|
Health Risk |
Likely pathogenic |
— |
| RS2545281070 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2545282121 |
TRIM37
|
Health Risk |
Pathogenic |
— |
| RS2545283571 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2545283716 |
MYO15A
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS2545284485 |
TRIM37
|
Health Risk |
Pathogenic |
— |
| RS2545285184 |
MYO15A
|
Health Risk |
Likely pathogenic |
— |
| RS2545286231 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2545287207 |
MYO15A
|
Health Risk |
Likely pathogenic |
— |
| RS2545290283 |
ALPL
|
Health Risk |
Likely pathogenic |
Adult hypophosphatasia, Adult hypophosphatasia |
| RS2545291966 |
ALPL
|
Health Risk |
Likely pathogenic |
Hypophosphatasia, Hypophosphatasia |
| RS2545291979 |
ALPL
|
Health Risk |
Likely pathogenic |
— |
| RS2545292172 |
ALPL
|
Health Risk |
Likely pathogenic |
Hypophosphatasia, Hypophosphatasia |
| RS2545292224 |
ALPL
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypophosphatasia, Hypophosphatasia |
| RS2545292484 |
ALPL
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypophosphatasia, Hypophosphatasia |
| RS2545292896 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2545292934 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2545293159 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2545294406 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2545295422 |
DYSF
|
Health Risk |
Likely pathogenic |
Miyoshi muscular dystrophy 1, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS2545295522 |
DYSF
|
Health Risk |
Likely pathogenic |
Miyoshi muscular dystrophy 1, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS2545295529 |
DYSF
|
Health Risk |
Likely pathogenic |
Miyoshi muscular dystrophy 1, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS2545295699 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS2545295851 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS2545297260 |
MYO15A
|
Health Risk |
Likely pathogenic |
— |
| RS2545298389 |
ALPL
|
Health Risk |
Pathogenic |
Adult hypophosphatasia, Hypophosphatasia |
| RS2545298399 |
ALPL
|
Health Risk |
Pathogenic |
— |
| RS2545298474 |
TLK2
|
Health Risk |
Likely pathogenic |
TLK2-related disorder, TLK2-related disorder |
| RS2545298581 |
ALPL
|
Health Risk |
Likely pathogenic |
Hypophosphatasia, Hypophosphatasia |
| RS2545298833 |
ALPL
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypophosphatasia, Hypophosphatasia |
| RS2545298876 |
ALPL
|
Health Risk |
Pathogenic |
— |
| RS2545298994 |
ABCB11
|
Health Risk |
Likely pathogenic |
— |
| RS2545299014 |
ALPL
|
Health Risk |
Conflicting classifications of pathogenicity |
Infantile hypophosphatasia, Infantile hypophosphatasia |
| RS2545299161 |
ALPL
|
Health Risk |
Likely pathogenic |
Childhood hypophosphatasia, Childhood hypophosphatasia |
| RS2545299251 |
ALPL
|
Health Risk |
Likely pathogenic |
Childhood hypophosphatasia, Adult hypophosphatasia |
| RS2545299615 |
ABCB11
|
Health Risk |
Likely pathogenic |
Benign recurrent intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 2 |
| RS2545299657 |
ALPL
|
Health Risk |
Likely pathogenic |
Childhood hypophosphatasia, Adult hypophosphatasia |
| RS2545299717 |
ABCB11
|
Health Risk |
Conflicting classifications of pathogenicity |
Benign recurrent intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 2 |
| RS2545300407 |
ABCB11
|
Health Risk |
Pathogenic |
— |